CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
PR Newswire•29/10/2026•07:00 ET
0
Key Highlights
- ➤November 12: CytoSorbents will report third-quarter 2026 results after market close.
- ➤November 12, 4:30 PM ET: Management will host a webcast and Q&A session.
- ➤CytoSorb has exceeded 300,000 cumulative devices used across more than 70 countries.
- ➤CytoSorbents targets cash-flow break-even in the second half of 2026.
- ➤DrugSorb-ATR remains unapproved in the U.S. and Canada, pending regulatory submissions.
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights PR Newswire
PRINCETON, N.J., Oct. 29, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report third quarter 2026 financial results and recent business highlights after the market close on Thursday, November 12, 2026.
Get started
Create a free account to read the full story.